**Background:** Exercise-induced immunosuppression is common among elite athletes after intensive training, increasing the risk of opportunistic infections, particularly upper respiratory tract infections (URTI). Secretory immunoglobulin A (SIgA) levels can decrease by up to 74.5% after heavy exercise and are inversely correlated with URTI risk. Prebiotics and synbiotics have shown promise in supporting immune function, but their comparative effects in football players during high-intensity training and strenuous exercise were poorly understood. This study aimed to compare the effects of six-week prebiotic versus synbiotic supplementation on URTI symptoms, inflammatory markers, mucosal immunity, and aerobic fitness in male university football players.
**Methods:** Thirty male university student-athletes from Beijing Sport University (mean football experience 9.87±0.58 years; 86.7% first-class players) were randomly assigned to a prebiotic group (PG, n=15) or synbiotic group (SG, n=15). Both supplements (2 g/day powder) were identical in packaging, color, and smell. The prebiotic contained galactooligosaccharides (GOS), fructooligosaccharides (FOS), inulin, polydextrose (PDX), strawberry powder, and maltitol. The synbiotic contained the same ingredients plus ≥8×10⁹ CFU of Lactobacillus casei Zhang, Bifidobacterium lactis V9, and ≥6×10⁹ CFU of Lactobacillus plantarum P-8. Supplements were taken once daily after lunch for six weeks. Participants maintained their normal diet and training schedule (>11 h/week). URTI symptoms were recorded daily via questionnaire. Saliva samples were collected before and after the intervention for SIgA, β-defensin (β-DF), α-amylase (AMS), and lysozyme (LZM) measurement. Venous blood was collected at baseline and immediately after a constant load exercise test (75% VO2max until exhaustion) for inflammatory cytokines (IL-1β, IL-4, IL-6, IL-8, IL-10, TGF-β1, IgA) and blood cell counts (WBC, RBC, Hb, HCT, MCH, MCHC). Aerobic capacity was assessed via VO2max test (Bruce protocol), maximal heart rate (HRmax), and lactic acid elimination rate (ER) from fingertip blood samples collected immediately, 1, 3, 5, and 10 minutes post-exercise. Statistical analysis used independent t-tests and repeated-measures ANOVA with SPSS 25; significance set at p<0.05.
**Key Results:** URTI incidence was significantly lower in the SG group (17.78±4.10% of symptomatic subjects) versus the PG group (31.11±3.30%, p<0.05). Total URTI symptom occurrences were markedly lower in SG (6.50±2.00 times/week) compared to PG (14.17±1.14 times/week, p<0.01). URTI duration was shorter in SG (1.77±0.19 days/time) than PG (2.66±0.28 days/time, p<0.05). Salivary SIgA increased significantly by 15.82% in the SG group (from 7.63±0.29 to 8.72±0.34 pg/mL, p<0.01) and was significantly higher than PG at final test (p<0.05). No significant changes were observed in β-DF, AMS, or LZM. At baseline, IL-1β increased significantly in SG (from 11.59±0.79 to 14.22±0.81 pg/mL, p<0.01) and by 13.61% in PG (p<0.05). IL-4 decreased significantly in PG (from 5.70±0.51 to 4.66±0.45 pg/mL, p<0.01). IL-6 increased by 31.87% in PG (p<0.05). Immediately after the constant load test, IL-1β decreased from 17.49±1.63 to 7.99±3.01 pg/mL in PG (p<0.01) and by 67.74% in SG (p<0.01). IL-4 decreased by 30.64% in PG (p<0.05) and from 6.82±0.77 to 3.28±1.27 pg/mL in SG (p<0.01). IL-10 decreased by 57.93% in SG and from 147.56±14.23 to 64.65±24.91 pg/mL in PG (both p<0.01). TGF-β1 decreased by 53.56% in PG and 74.12% in SG (both p<0.01). Blood cell counts showed significant time effects for RBC (p=0.009, η²=0.320), Hb (p=0.001, η²=0.460), HCT (p=0.011, η²=0.306), MCH (p<0.001, η²=0.602), and MCHC (p<0.001, η²=0.708), with significant time×group interactions for RBC (p=0.001, η²=0.446), Hb (p=0.001, η²=0.448), and HCT (p=0.001, η²=0.453). VO2max did not change significantly in either group. HRmax during constant load exercise decreased significantly in SG (from 174.10±3.35 to 168.88±4.70 bpm, p<0.05). Lactic acid ER increased by 193.78% in SG (from 0.33±0.06% to 0.76±0.13%, p<0.01) but not in PG.
**Clinical Implications:** This study provides evidence that six weeks of synbiotic supplementation is superior to prebiotic supplementation alone in reducing URTI incidence and duration, enhancing mucosal immunity (SIgA), and improving lactate metabolism and heart rate efficiency in male university football players undergoing high-intensity training. The synbiotic group showed a shift toward a more pro-inflammatory cytokine profile at rest (increased IL-1β) and reduced anti-inflammatory cytokines (IL-4, IL-10, TGF-β1) after strenuous exercise, suggesting improved immune regulation. The 193.78% increase in lactic acid elimination rate and reduced HRmax in the synbiotic group indicate potential performance benefits. These findings support the use of synbiotics as a nutritional strategy for athletes to maintain immune function and possibly enhance recovery during heavy training periods. However, the absence of a true placebo control group limits the ability to attribute effects solely to the synbiotic versus prebiotic comparison. Future studies should include a placebo group and investigate the underlying mechanisms linking gut microbiota modulation to immune and metabolic outcomes.